Dr. Ibiayi Dagogo-Jack, MD
Claim this profileMassachusetts general Hospital
Area of expertise
Lung Cancer
Ibiayi Dagogo-Jack, MD has run 5 trials for Lung Cancer. Some of their research focus areas include:
Mesothelioma
Ibiayi Dagogo-Jack, MD has run 4 trials for Mesothelioma. Some of their research focus areas include:
Affiliated Hospitals
Massachusetts General Hospital
Massachusetts General Hospital Massachusetts General Hospital
Clinical Trials Ibiayi Dagogo-Jack, MD is currently running
More about Ibiayi Dagogo-Jack, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Ibiayi Dagogo-Jack, MD has experience with
- Pembrolizumab
- Lorlatinib
- Alectinib
- Cobimetinib
- IAG933
- Anetumab Ravtansine
Breakdown of trials Ibiayi Dagogo-Jack, MD has run
Lung Cancer
Mesothelioma
Non-Small Cell Lung Cancer
- KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC
- Lorlatinib Combinations in Lung Cancer
- A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions
Malignant Pleural Mesothelioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ibiayi Dagogo-Jack, MD specialize in?
Ibiayi Dagogo-Jack, MD focuses on Lung Cancer and Mesothelioma. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ibiayi Dagogo-Jack, MD currently recruiting for clinical trials?
Yes, Ibiayi Dagogo-Jack, MD is currently recruiting for 1 clinical trial in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Ibiayi Dagogo-Jack, MD has studied deeply?
Yes, Ibiayi Dagogo-Jack, MD has studied treatments such as Pembrolizumab, Lorlatinib, Alectinib.
What is the best way to schedule an appointment with Ibiayi Dagogo-Jack, MD?
Apply for one of the trials that Ibiayi Dagogo-Jack, MD is conducting.
What is the office address of Ibiayi Dagogo-Jack, MD?
The office of Ibiayi Dagogo-Jack, MD is located at: Massachusetts general Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts general Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.